Vaccination for Monkeypox Disease
Clinical and Biological Aspects of the MONKEYPOX Disease
Recruiting
N/A
Interventional Study
Monkey Pox
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Basic Science
- Participants needed
- 330 (estimated)
- Sponsor
- Institut Pasteur · Industry
Who this trial is looking for
This trial is looking for adults who are eligible for monkeypox vaccination or have a suspicion of monkeypox infection. Participants will provide a blood sample and must agree to take part in the study.
Are You a Good Fit for This Trial?
You may be able to join if
- I am an adult.
- I am eligible for monkeypox vaccination or suspected of monkeypox infection.
- My health allows me to give a 45 ml blood sample.
- I have agreed to participate in the study.
- I have Social Health Insurance coverage.
You may not be able to join if
- I have been vaccinated for monkeypox without proof.
- I have a contraindication to vaccination other than a current infection.
- I am pregnant or breastfeeding.
- I cannot give informed consent to participate.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Monkey pox virus (MPXV), of the genus Orthopoxvirus, regularly causes epidemics in endemic areas of central and western Africa.
Since January 1, 2022, cases of Monkey pox have been reported to WHO by 96 Member States in the 6 WHO regions. As of 22 August 2022, a total of 41,664 laboratory-confirmed cases and 192 probable cases, including 12 deaths, have been reported to WHO. Since May 13, 2022, a…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Adult,
* eligible for MPXV vaccination according to HAS criteria or suspected of MPXV infection
* whose health status is compatible with a 45 ml single blood sample
* who have consented to participate in the study
* who are covered by a Social Health Insurance plan
Exclusion …
Contacts